Systematic analysis of the clinical and biochemical characteristics of maternally inherited hypertension in Chinese Han families associated with mitochondrial by Yuqi Liu et al.
Liu et al. BMC Medical Genomics  (2014) 7:73 
DOI 10.1186/s12920-014-0073-xRESEARCH ARTICLE Open AccessSystematic analysis of the clinical and
biochemical characteristics of maternally
inherited hypertension in Chinese Han families
associated with mitochondrial
Yuqi Liu1†, Qinglei Zhu1, Chao Zhu1†, Xueping Wang1, Jie Yang1, Tong Yin1, Jinliao Gao1, Zongbin Li1,
Qinghua Ma5, Minxin Guan2,3,4, Yang Li1,6* and Yundai Chen1,6*Abstract
Background: Mitochondrial DNA mutations may be associated with cardiovascular disease, including the common
cardiac vascular disease, hypertension.
Methods: In this study we performed segregation analysis and systematically evaluated the entire mitochondrial
genome in nine maternally inherited hypertension probands from Chinese Han families. We also performed clinical,
genetic and molecular characterization of 74 maternally inherited members from these families and 216 healthy
controls.
Results: In the maternally inherited members, 12 had coronary heart disease (CHD), six had cerebrovascular disease,
five had diabetes, nine had hyperlipidemia and three had renal disease. Laboratory tests showed that the sodium
and potassium levels in blood of the maternally inherited members were higher than those of the control group
(P < 0.01), while no differences were observed in fasting blood glucose (FBG), total cholesterol (TC), triglyceride, low
density lipoprotein cholesterol (LDL-c) and creatinine levels (P > 0.05). The high density lipoprotein cholesterol
(HDL-c) level of the maternally inherited members was lower than that of the control group (P = 0.04). The whole
mitochondrial DNA sequence analysis revealed a total of 172 base changes, including 17 in ribosomal RNA (rRNA)
genes, four in transfer RNA (tRNA) genes, and 22 amino acid substitutions. The remainder were synonymous
changes or were located in non-coding regions. We identified seven amino acid changes in the nine maternally
inherited hypertension families, including four mutations in ATPase6 and three in Cytb. More interestingly, tRNASer
(UCN) 7492 T > C was absent in controls and was present in <1% of 2704 mtDNAs, indicating potential functional
significance.
Conclusions: This study showed that mutations in mtDNA may contribute to the pathogenesis of hypertension in
these Chinese Han families. In the near future, identification of additional mtDNA mutations may indicate further
candidate genes for hypertension.
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Hypertension is a major public health problem, affecting
approximately 1 billion people worldwide [1]. Hyperten-
sion is also a major risk factor for coronary heart dis-
ease, stroke, congestive heart failure and renal disease
[2]. Essential hypertension is commonly regarded as a
multifactorial disease influenced by both genetic and en-
vironmental factors. Familial aggregation of high blood
pressure, despite different environmental factors, sug-
gests that genetic factors are involved in the etiology of
hypertension [3,4]. Estimates of genetic variance range
from 20% to 50% [5-7].
Early and more recent investigations [8,9] show signifi-
cant maternal familial aggregation of high blood pres-
sure, which suggests a contribution of the mitochondrial
genome to hypertension [10]. Our previous studies have
reported excess maternal transmission of hypertension
(HTN) in hypertensive families associated with tRNA
point mutations [11-15]. Here we report mtDNA muta-
tions, including previously unreported mutations, in 108
hypertension patients and 216 healthy controls.
Methods
Subjects
As part of a genetic screening program for hypertension,
324 subjects, including 108 hypertension patients and
216 controls, were ascertained at the Institute of Geriat-
ric Cardiology of the Chinese People’s Liberation Army
(PLA) General Hospital. Control subjects underwent
physical examination, provided family medical history,
and provided samples for laboratory assessment at least
twice in 1 year. Hypertension was defined according to
the recommendations of the Joint National Committee
on Detection, Evaluation and Treatment of High Blood
Pressure (JNC VI) [16] as a systolic blood pressure of
140 mmHg or higher and/or a diastolic blood pressure
of 90 mmHg or greater.
We performed segregation analysis on 108 hyperten-
sion patients to identify maternally inherited hyperten-
sion. We applied the following exclusion criteria: a. the
proband’s father suffered from hypertension; b. if the
proband was male, and one or more of his offspring suf-
fered from hypertension; c. neither the proband’s mother
nor her offspring presented with hypertension; d. the
probands’ spouses presented with high blood pressure;
e. inheritance was consistent with autosomal recessive,
autosomal dominant, X-linked, and Y-linked patterns
(see reference [17]). These criteria resulted in the exclu-
sion of 99 probands. The other nine probands presented
with a maternally inherited pattern. Their families (in-
cluding a further 65 maternally inherited members) and
216 healthy controls were interviewed and evaluated to
identify both personal or medical histories of hyperten-
sion and other clinical abnormalities. Medical history,including coronary heart disease (CHD), cerebrovascular
disease, diabetes, hyperlipidemia and renal disease, was
also evaluated. Patients reporting cigarette use within
1 year prior to examination were considered as smokers.
Body mass index (BMI) (Kg/m2) is defined as an individ-
ual’s body mass divided by the square of their height.
BMI of 18.5 to 25 indicates optimal weight. All patients
had a standard 12-lead ECG recording at 25 mm/s
and 1 mV/cm. Left ventricular hypertrophy (LVH) was
assessed according to traditional Sokolow-Lyon voltage
criteria (SV1 + RV5 or RV6 ≥ 3.5 mV) or to gender-
specific Cornell voltage (RaVL + SV3 ≥ 2.8 mV in men or
≥2.0 mV in women) criteria. Total DNA samples of the
65 (non-proband) maternal members and 216 healthy
controls were acquired for sequence analysis. Informed
consent was obtained from all participating members.
All participating members are fully informed of the
purpose of the study, the test items (including the phys-
ical examination, family medical history, and blood sam-
ples for laboratory assessment and sequencing analysis),
the results of the laboratory assessment and sequencing
analysis. All the patients were fully informed the study
and signed the informed consent to join the study and
consent to publish their individual data. All the proto-
cols were approved by the ethics committee of the Chin-
ese PLA General Hospital.
mtDNA sequencing and sequence analysis
Genomic DNA was isolated from whole blood cells of
participants using Puregene DNA Isolation Kits (Gentra
Systems, Minneapolis, MN, USA). The entire mitochon-
drial genome of HTN subjects and controls was PCR-
amplified in 24 overlapping fragments using light-strand
and heavy-strand sets of oligonucleotide primers [18].
Each fragment was purified and subsequently analyzed
by direct sequencing on an ABI 3700 automated
DNA sequencer (Applied Biosystems, Inc., Foster City,
CA, USA) using the Big Dye Terminator Cycle sequen-
cing reaction kit. The resultant sequence data were
compared with the revised consensus Cambridge
sequence (GenBank accession No. NC-012920, http://
www.mitomap.org/MITOMAP) [19]. All mtDNA muta-
tions were individually analyzed using the MitoAnalyzer
(National Institutes of Standards and Technology,
Gaithersburg, MD, USA, http://www.cstl.nist.gov/biotech/
strbase/mitoanalyzer.html) and the MITOMAP database
[20]. The haplogroups were deduced by comparing the
complete mtDNA sequence data with the previously re-
ported haplogroup-specific variants [21]. To analyze the
phylogeny of tRNAs, we used vertebrate mitochondrial
DNA sequences for interspecific analysis, including from
Bos Taurus, Cebus albifrons, Gorilla gorilla, Homo sapiens,
Hylobates lar, Lemur catta, Macaca mulatta, Macaca syl-
vanus, Mus musculus, Nycticebus coucang, Pan paniscus,
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pygmaeus, Tarsius bancanus, and Xenopus laevis (Gen-
Bank). The conservation index (CI) was calculated by
comparing the human nucleotide variants with the other
16 vertebrates. The CI was then defined as the percentage
of species from the list of 17 vertebrates that have the
wild-type nucleotide at that position.
Statistical analysis
Statistical analyses were performed using the Statistical
Package for Social Sciences software (SPSS version 13.0).
Continuous variables with normal distributions were
expressed as means ± SD and compared using a t test.
Categorical variables were compared using the chi-
squared test where appropriate.
Results
Clinical evaluation and inheritance analysis in nine
families
As shown in Figure 1 and Table 1, there were three male
probands (indicated by arrows), HTN-1 (Figure 1A),
HTN-8 (Figure 1H) and HTN-9 (Figure 1I). All of their
mothers suffered from high blood pressure, and none
of their offspring had hypertension. One brother (II-3,Figure 1 Nine Chinese Han pedigrees with maternally inherited hype
denote probands. I means first generation; II means second generation; III mFigure 1A) and three out of four sisters (II-6, 8, 10) of
HTN-1 also had hypertension. HTN-8’s brother (II-5,
Figure 1H) and one of two sisters (II-2) suffered from
hypertension, but no offspring of HTN-8 or his brother
presented with high blood pressure. Only one daughter
of his sister (III-3) had hypertension. One out of two
brothers (II-3) of HTN-9 had hypertension, but no off-
spring of HTN-9 or his brothers presented with high
blood pressure. Similarly, we found that in the families
of the female probands (HTN-2, 3, 4, 5, 6 and 7, Figure 1B,
C, D, E, F, G) only the offspring of the affected female pa-
tients presented with hypertension. There was no evidence
that any member of this family had any other cause to
account for hypertension. Therefore, the inheritance
pattern of all nine probands was consistent with mater-
nal inheritance.
Of the nine probands, three were male patients in the
age range of 40 to 75 years old. They came to the Chin-
ese PLA General Hospital Cardiology Clinic for clinical
evaluations. Onset-age ranged from 30 to 72 years old.
Their blood pressure ranged from 140/90 to 180/
100 mm Hg. HTN-3 and HTN-8 presented with LVH
upon ECG examination. Echocardiography showed mild
thickening of the interventricular septum in HTN-3,rtension. Affected individuals are indicated by filled symbols. Arrows
eans third generation.
Table 1 Summary of Clinical Data for 9 probands with HTN





















HTN1 M 58 58 53.8(13) 160 80 9 87.2 N 125.3
HTN2* F 62 53 50.0(12) 160 96 10 90.5 N 74.7
HTN3* F 61 45 57.1(7) 154 88 13 112.3 LVH 117.7
HTN4* F 40 33 71.4(7) 140 90 11 101.7 N 111.5
HTN5* F 62 51 57.1(7) 160 80 12 92.7 N 130.1
HTN6* F 56 56 50.0(12) 150 100 12 98.4 N 114.9
HTN7* F 58 40 55.6(9) 180 100 13 91.2 N 65.3
HTN8* M 52 30 62.5(8) 160 110 13 97.1 LVH 102.7
HTN9 M 75 72 75.0(4) 180 80 10 117.9 N 77.2
*These patients received antihypertension treatment. This table shows pretreatment blood pressures. eGFR indicates estimated glomerular filtration rate; F, female; IVST,
interventricular septal thickness; LVH, ECG showed left ventricular hypertrophy; LVMI, left ventricular mass index; M, male; N, electrocardiography (ECG) was normal.
Table 2 Cinical data for maternal members of the
probands and the controls
Maternal




Mean ± SD Mean ± SD
Men, n (%) 28 52 0.07
Age (years) 60.9 ± 12.3 55.9 ± 10.8 0.15
Onset age(years) 45.6 ± 9.8
BMI (kg/m2) 25.1 ± 4.8 24.1 ± 3.1 0.00*
Systolic BP (mmHg) 132.8 ± 29.6 117.9 ± 9.8 0.00*
Diastolic BP (mmHg) 79.3 ± 17.4 66.8 ± 9.1 0.00*
Past disease
CHD 12 0 0.00*
Cerebrovacular disease 6 0 0.00*
Diabetes 5 0 0.00*
Hyerlipidemia 9 0 0.00*
Renal disease 3 0 0.02*
Alcohol 9 18 0.56
Current Smoking 18 21 0.01*
Laboratory test
FSB (mmol/L) 5.7 ± 1.5 5.5 ± 1.8 0.38
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thickening did not reach the echocardiography standard
for LVH diagnosis (male patient larger than 125 g/m2,
female patient larger than 115 g/m2). We also calculated
the estimated glomerular filtration rate (eGFRs) accord-
ing to the abbreviated Modification of Diet in Renal Dis-
ease formula [22], and found that HTN-2, HTN-7 and
HTN-9 had mild renal dysfunction with eGFRs lower
than 90 mL/min/1.73 m2 (see Table 1).
We collected clinical data from the maternal family
members of the nine probands (a total of 74 maternal
family members) and 216 healthy controls (see Table 2).
The average age was 60.9 ± 12.3 versus 55.9 ± 10.8 years
for controls with no significant difference. The systolic
blood pressure (SBP) and diastolic blood pressure (DBP)
of the maternal group were higher than those of con-
trols, 132.8 ± 29.6 versus 117.9 ± 9.8 and 79.3 ± 17.4
versus 66.8 ± 9.1, respectively, both P < 0.01. Twelve ma-
ternal members had CHD, six cerebrovascular disease,
five diabetes, nine hyperlipidemia, and three renal dis-
ease. Laboratory tests showed no significant changes in
FBG, TC, triglyceride, LDL-c and creatinine (P > 0.05).
The sodium and potassium levels of the maternal family
members were higher than those in controls (P < 0.01),
while the HDL-c level was lower than that of controls
(P = 0.04).TC (mmol/L) 4.3 ± 0.8 4.1 ± 1.0 0.11
Sodium (mmol/L) 141.2 ± 3.6 139.4 ± 3.2 0.00*
Potassium (mmol/L) 4.3 ± 0.4 4.1 ± 0.5 0.00*
Triglyceride (mmol/L) 1.7 ± 0.9 1.5 ± 0.8 0.07
HDL (mmol/L) 1.1 ± 0.3 1.2 ± 0.4 0.04*
LDL (mmol/L) 2.6 ± 0.6 2.5 ± 0.8 0.31
Creatinine (μmol/L) 61.4 ± 11.1 59.1 ± 15.8 0.23
CHD, coronary heart disease; FSB, fasting blood glucose; TC, total cholesterol;
HDL, High-density lipoprotein; LDL, low-density lipoprotein; UN, Urea nitrogen.
* present statistically significant difference.Analysis of coding and control region mutations
We sequenced the entire mitochondrial genome in the
nine probands. Twenty-four overlapping fragments,
including 37 genes, were PCR-amplified, purified and
subsequently analyzed by DNA sequencing. All variants
were compared with the data in mitomap (http://www.
mitomap.org) [20] and Phylotree (http://www.phylotree.
org/). Comparison with the “revised Cambridge” refer-
ence sequence (rCRS) [19,23] revealed a total of 172
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Table 3). All 172 variants identified in the probands were
compared with the reference sequence and with corre-
sponding sequence from 216 controls. Among the vari-
ants, 151 were located in the coding or control regions
of genes, including 77 variants in the D-loop, four in
ND1, five in ND2, seven in COI, six in COII, two in
ATPase8, 13 in ATPase6, three in COIII, four in ND3,
one in ND4L, five in ND4, seven in ND5, four in
ND6 and 13 in Cytb. Twenty-four of the 151 variants
were not identified in the controls or in 2704 control
mtDNAs [24] and 22 variants were non-synonymous.
To discover mutations associated with hypertension, we
screened the other 65 maternally inherited members (74
minus the nine probands) for these 151 mutations. We
identified COI 7028C > T and Cytb 15326A > G in all
maternal members of HTN2, ND2 4769A > G, ATPase6
8584G > A and 8701A > G in HTN3, ATPase8 8413A > G
in HTN4, D-loop 750A > G and ND5 12705C > T in
HTN5, ATPase6 8803A > G in HTN6, COIII 9950C > T,
Cytb 15662A > G and 15851A > G in HTN7, ATPase8
8413A > G, ATPase6 8794C > T and Cytb 15379C > T
in HTN8, COIII 9380G > A and D-loop 16278C > T in
HTN9. These changes include seven non-synonymous
changes associated with amino acid substitutions.Table 3 All mtDNA variants in the nine probands with HTN
Location Total variants Num of Amino
acid changes
New reported
D-loop 78 - 24
12S rRNA 6 - 0
16S rRNA 11 - 5
ND1 4 0 1
tRNAGln 1 - 0
ND2 5 2 2
COI 7 0 2
tRNA Ser(UCN) 1 - 1
COII 6 0 0
ATPase8 2 1 0
ATPase6 13 6 6
COIII 3 0 0
ND3 4 2 0
ND4L 1 0 0
ND4 5 1 0
ND5 7 2 2
ND6 4 3 0
tRNA Glu 1 - 1
Cytb 13 5 0
tRNA Thr 1 0 0
See http//www.mitomap.org and http://www.genpat.uu.se/mtDB/ for
more information.rRNA/tRNA mutation analysis
DNA fragments spanning the 12S rRNA, 16S rRNA and
22 tRNA genes were PCR-amplified from mitochondrial
DNA of the nine probands. We identified 21 nucleotide
changes, including six variants in the 12S rRNA gene, 11
in the 16S rRNA gene and four variants in four tRNA
genes (see Additional file 1 and Table 3). There were
six novel mutations, including 2448G > A, 2534G > A,
2673G > A, 2695G > A, 2706A > G in 16S rRNA and
14686G > A in tRNAGlu. All the nucleotide changes were
verified by sequence analysis of both strands and ap-
peared to be homoplasmic. We also identified the 21
mutations in the other 65 maternally inherited members.
We identified 12S rRNA 1005 T > C, 16S rRNA 1824
T > C and tRNASer(UCN) 7492C > T in all maternally
inherited members of HTN1, 12S rRNA 1438A > G and
16S rRNA 2706A > G in HTN2, 12S rRNA 1438A > G
and 16S rRNA 2706A >G in HTN5, tRNA
Thr 15927G >A
in HTN7, and 16S rRNA 1736G >A in HTN8.
To evaluate the effect of the variants on mitochondrial
tRNA structure and function, we localized each variant
to either the stem or loop of tRNA secondary structures.
As shown in Figure 2, tRNAGln 4386 T > C was located
in the loop, tRNAThr 15927G > A and tRNASer(UCN)
7492 T > C were located in the anti-codon stem, and
tRNAGlu 14684G > A was located in the T-stem. In
addition, a phylogenetic analysis was performed by com-
paring the human tRNA nucleotide variants with those
in 16 other vertebrates. The CI was 31.2% in tRNAGlu
14684G > A, 56.2% in tRNAThr 15927G > A, 62.5% in
tRNAGln 4386 T > C and 81.2% in tRNASer(UCN) 7492 T
> C. tRNAGlu 14684G > A was absent in healthy controls
and in 2704 mtDNAs, tRNASer(UCN) 7492 T > C was ab-
sent in the controls and was observed in <1% of 2704
mtDNAs, while tRNAThr 15927G > A and tRNAGln
4386 T > C were present in this control population and
in >1% of 2704 mtDNAs. Based on these criteria, tRNA-
Ser(UCN) 7492 T > C may have functional significance.
Discussion
Maternal inheritance has several characteristics. Males
and females inherit mitochondrial diseases equally, but
always from their mother. A father cannot pass on mito-
chondrial disease to his children. In this study, we iden-
tified nine maternally inherited hypertension families
from 108 hypertension individuals. Maternal influences
on blood pressure can be explained by X-chromosomal
inheritance, chromosomal imprinting [25], gestational
mechanisms [26,27] and mitochondrial disorders [28].
For autosomal inheritance, morbidity in offspring of af-
fected mothers should be equal to that in offspring
of affected fathers. However, none of the offspring of
affected fathers in these families had hypertension, so
autosomal inheritance could be rejected. For X-linked
Figure 2 Mitochondrial tRNA variants in subjects from nine Chinese Han pedigrees. Cloverleaf structures of canonical tRNA and four
mitochondrial tRNAs are shown. Arrows indicate the positions of the tRNA mutations.
Liu et al. BMC Medical Genomics  (2014) 7:73 Page 6 of 8inheritance, only females are affected, but all these
families had both male and female patients, so X-linked
inheritance could also be rejected. Gestational mechanisms
could be excluded because the ratio of affected offspring
from a hypertensive mother should be less than 50%; how-
ever, this ratio in all families was equal to or larger than
50%. Mitochondrial DNA abnormality is by far the most
likely explanation for the etiology of hypertension in these
pedigrees.
Essential HTN is a polygenic disease; however, efforts
to identify genetic determinants of HTN have been
directed primarily towards the nuclear genome, whereas
the role of the mitochondrial genome remains relatively
unexplored. Recently, we reported that mitochondrial
DNA mutations contribute to HTN, including ND1
3308, tRNAMet 4435, tRNAIle 4263, tRNAIle 4295
[11-15]. These studies focused on tRNA mutations. To
identify further variants in the mitochondrial genome
that contribute to HTN, we analyzed the entire mito-
chondrial genome (mtDNA) in hypertensive probands
from families with typical maternally inherited hyperten-
sion. The entire human mitochondrial DNA sequence,
of only 16 kb, has been mapped and encodes 13 proteins
two rRNAs, and 22 tRNAs. In this study, we describe a
total of 172 variants in the nine probands compared
with the “Cambridge” reference sequence (CRS), includ-
ing 77 variants in the D-loop, four in ND1, five in ND2,
seven in COI, six in COII, two in ATPase8, 13 in
ATPase6, three in COIII, four in ND3, one in ND4L,
five in ND4, seven in ND5, four in ND6, and 13 in
Cytb. In addition we found six variants in 12S rRNA,
11 in 16S rRNA and four in four tRNA genes (see
Additional file 1 and Table 3). Of these 172 variants, 30
were not identified in the control subjects or in 2704
mtDNAs.
To investigate the contribution of these mutations
to maternally inherited hypertension, we identified the
172 mutations in all maternally inherited members from
the nine families. Remarkably, there were seven non-synonymous changes associated with amino acid substi-
tutions, including four mutations in the ATP synthase
F0 subunit 6, and three in cytochrome b. Among these
mutations, ATPase6 8794C > T is associated with exer-
cise endurance/coronary atherosclerosis risk, [29,30] and
Cytb 15662G > A is associated with complex mitochon-
driopathy [31]. The other five amino acid changes have
not been previously reported. We also identified two
mutations in 12S rRNA (1005 T > C and 1438A > G) and
three in 16S rRNA (1736A>G, 1824 T >C and 2706A>G).
tRNASer(UCN) 7492C > T and tRNAThr 15927G > A pre-
sented in all maternal members of the probands. 12S
rRNA 1005 T > C has been associated with deaf, [32] while
12S rRNA 1438A >G may be involved with schizophrenia,
bipolar disorder, and major depressive disorder [33] The
CI was 56.2% for tRNAThr 15927G > A and 81.2% for
tRNASer(UCN) 7492 T > C. tRNASer(UCN) 7492 T > C was
absent in the controls and present at <1% in 2704
mtDNAs, while tRNAThr 15927G >A was present in this
control population and at >1% in 2704 mtDNAs. Based on
these criteria, tRNASer(UCN) 7492 T > C mutations may
have functional significance.
Conclusions
In this study, complete sequencing of the mitochondrial
genome from nine maternally hypertensive probands
allowed us to detect novel and previously unreported
mtDNA variants. Several of the more common muta-
tions have been previously reported to be associated
with cardiovascular disease, such as 10398A > G, which
is associated with end-stage renal disease in African
Americans with HTN [34]. In summary, several mtDNA
mutations may contribute to hypertension. In the future,
additional mtDNA mutations may be discovered that
could indicate candidate genes for hypertension. Thus,
our findings provide new understanding of the patho-
physiology of HTN and valuable information for the
management and treatment of maternally inherited
hypertension. For the members of these families with
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follow-up and promoted secondary prevention, including risk
factor control, use of medications, and self-management.
Future research should further explore the emerging link
between hypertension and mitochondrial dysfunction, and
their cause/effect relationship.
Additional file
Additional file 1: mtDNA variants in 9 Han Chinese probands with
hypertension.
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